SCHEMBL30712065

SCHEMBL30712065

CCCNC(=O)C(=O)c1c[nH]c2c(Br)cc(F)c(OCc3ccccc3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ BRD4 O60885 2/20 0.37
▸ THRA P10827 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30712094 0.92 BRD4 (0.42) KMT2ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL31708089 0.88 SMN1; SMN2 (0.42) KMT2ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL31708198 0.86 THRA (0.37) NPC1SMN1; SMN2THRATHRB
SCHEMBL1163916 0.85 LMNA (0.40) KMT2ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL31708099 0.84 THRA (0.42) KMT2ANPC1SMN1; SMN2THRATHRB
SCHEMBL31708095 0.83 THRA (0.44) NPC1SMN1; SMN2THRATHRB
SCHEMBL30712089 0.75 DPP4 (0.36) NPC1THRATHRB
SCHEMBL1163307 0.74 THRB (0.45) KMT2ANPC1SMN1; SMN2POLBMAPT
SCHEMBL31614675 0.74 NPC1 (0.50) KMT2ARAB9ANPC1SMN1; SMN2POLB
SCHEMBL4391284 0.73 LTB4R (0.37) KMT2ANPC1SMN1; SMN2POLBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
EP-4551212-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024035757-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2024-02-15 — — WO disclosed
Send feedback